Associated Papers
Understanding pain perception through genetic painlessness diseases: The role of NGF and proNGF.
Testa G et al.
Pharmacological Research, 2021
RUNX1 mutations in blast-phase chronic myeloid leukemia associate with distinct phenotypes, transcriptional profiles, and drug responses.
Adnan Awad S et al.
Leukemia, 2021
32782381 (PubMed )
Supplement: 41375_2020_1011_MOESM5_ESM.xlsx › Mutation_in_Australian_cohort
A missense point mutation in nerve growth factor (NGFR100W) results in selective peripheral sensory neuropathy.
Yang W et al.
Progress in Neurobiology, 2020
Nerve growth factor and the physiology of pain: lessons from congenital insensitivity to pain with anhidrosis.
Indo Y
Clinical Genetics, 2012
Taking pain out of NGF: a "painless" NGF mutant, linked to hereditary sensory autonomic neuropathy type V, with full neurotrophic activity.
Capsoni S et al.
Plos One, 2011
A novel NGF mutation clarifies the molecular mechanism and extends the phenotypic spectrum of the HSAN5 neuropathy.
Carvalho OP et al.
Journal of Medical Genetics, 2011
A third HSAN5 mutation disrupts the nerve growth factor furin cleavage site.
Shaikh SS et al.
Molecular Pain, 0
Select a paper to view details